rs2967677 — CERS4 Ceramide synthase 4 locus variant

The Ceramide Locus — When Skin Lipid Metabolism Shapes Allergy Risk

Your skin's outermost layer, the stratum corneum, is a lipid-rich barrier that keeps allergens, irritants, and pathogens out while preventing water from evaporating out¹¹ out
the stratum corneum lipid matrix — roughly equal proportions of ceramides, cholesterol, and free fatty acids — forms lamellar membrane structures that are the primary barrier. Of those lipids, ceramides are the dominant structural component. When ceramide composition shifts, barrier integrity falls, and the skin becomes permeable to environmental antigens that then trigger the IgE-dominated immune response that characterises atopic dermatitis.

rs2967677 sits in the 3' untranslated region of NFILZ on chromosome 19p13.2, roughly 400 kilobases downstream of CERS4 (ceramide synthase 4). The T risk allele was identified in a large multi-ancestry GWAS meta-analysis²² large multi-ancestry GWAS meta-analysis
Budu-Aggrey et al. "European and multi-ancestry GWAS meta-analysis of atopic dermatitis highlights importance of systemic immune regulation." Nature Communications, 2023 as a genome-wide significant atopic dermatitis risk variant. The biological attribution to the CERS4 locus reflects the ceramide pathway biology in the region — CERS4 catalyses the synthesis of very-long-chain ceramides (C18–C22 acyl chains) that are essential for skin barrier architecture, while NFILZ encodes a transcription factor related to NFIL3/E4BP4, a known regulator of IgE receptor function in basophils.

The Mechanism

CERS4 is one of six ceramide synthase enzymes and is the principal source of C18:0 and C20:0 ceramide species in the epidermis³³ epidermis
ceramide synthase enzymes differ in their acyl-chain length specificity: CerS2 produces C22-C24, CerS4 produces C18-C22, CerS5/CerS6 produce C14-C16. Atopic dermatitis skin is consistently deficient in ceramides relative to healthy skin, and the species composition is altered — shorter-chain ceramides predominate while the very-long-chain species that form the most water-impermeable lamellar structures are depleted. Work on CERS4-deficient mice confirmed the mechanistic link: deletion of CerS4⁴⁴ deletion of CerS4
Peters et al. J Cell Biol 2025: CerS4 knockout produced an AD-like skin phenotype with T helper cell 2 immune infiltration and progressive barrier failure in mouse epidermis disrupts hair follicle stem cell development and produces a Th2-dominant inflammatory skin phenotype that closely resembles human atopic dermatitis, with impaired barrier integrity driving the immune activation.

The NFILZ gene co-localising with rs2967677 is a paralog of NFIL3/E4BP4, a circadian transcription factor that also governs basophil maturation and IgE receptor function. NFIL3/E4BP4⁵⁵ NFIL3/E4BP4
Sharma et al. J Allergy Clin Immunol 2024: NFIL3 controls the late-stage acquisition of IgE receptor signalling capacity in maturing basophils; conditional deletion impaired IgE-mediated cytokine secretion and degranulation in an allergic dermatitis model deletion compromises IgE receptor signalling, cytokine secretion, and degranulation in basophils — the exact effector cells that amplify the allergic response in atopic dermatitis. The T allele of rs2967677, located in the 3'UTR of NFILZ, may alter mRNA stability or post-transcriptional regulation of this related factor, contributing to dysregulated IgE-mediated inflammation. The locus is therefore mechanistically double-barrelled: ceramide deficiency from impaired CerS4 function opens the barrier, and altered NFILZ/NFIL3 signalling amplifies the inflammatory response once environmental antigens cross it.

The Evidence

The primary association evidence comes from the Budu-Aggrey et al. 2023 multi-ancestry GWAS meta-analysis⁶⁶ Budu-Aggrey et al. 2023 multi-ancestry GWAS meta-analysis
European and multi-ancestry GWAS meta-analysis of atopic dermatitis highlights importance of systemic immune regulation. Nature Communications 14, 6483 (2023), one of the largest AD genetic studies assembled. rs2967677-T reached genome-wide significance with an odds ratio of 1.06 (95% CI 1.05–1.07) at p=8×10⁻⁴⁹ — a highly significant and well-powered signal despite a modest per-allele effect size. The strength of the p-value reflects the large sample size rather than a large individual effect; each T allele increases the odds of developing atopic dermatitis by approximately 6%.

The functional relevance of ceramides to atopic dermatitis is independently established by Ito et al. 2017⁷⁷ Ito et al. 2017
Ceramide synthase 4 is highly expressed in involved skin of patients with atopic dermatitis. J Eur Acad Dermatol Venereol, 2017, who showed that CERS4 mRNA is significantly elevated in active AD lesions relative to the same patient's uninvolved skin (p<0.01), and that CERS4 expression correlates with accumulation of the shorter-chain C34-Cer[NS] species and with reduced stratum corneum hydration. This apparent upregulation during disease is interpreted as a compensatory or maladaptive response to the altered ceramide environment rather than the primary driver — the causal direction of the GWAS signal points toward impaired ceramide metabolism as a risk factor rather than a consequence.

Clinical translation of the ceramide deficit is supported by multiple randomised trials. Draelos et al. 2017⁸⁸ Draelos et al. 2017
Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer. J Drugs Dermatol, 2017 showed that a ceramide-containing moisturiser significantly delayed disease flares compared to vehicle in paediatric AD. The 2025 randomised study by Kwon et al.⁹⁹ Kwon et al.
Topical supplementation with physiological lipids rebalances the stratum corneum ceramide profile and strengthens skin barrier function in adults predisposed to atopic dermatitis. 2025 confirmed that topical physiological lipid supplementation measurably restores the ceramide profile and strengthens barrier function in at-risk adults.

Practical Actions

Carriers of the T risk allele — and especially TT homozygotes — have a genetic predisposition toward the ceramide deficiency that characterises AD-prone skin. The most evidence-supported intervention is consistent use of ceramide-containing topical emollients, which directly address the underlying lipid deficit.

The ceramide emollient strategy is not generic moisturiser advice: it requires formulations containing the specific ceramide classes depleted in AD skin (ceramide NP, AP, and EOP in combination with cholesterol and free fatty acids, mimicking physiological lamellar structure). Products formulated with a physiological lipid ratio outperform plain occlusives or single-ceramide preparations in barrier restoration studies.

Dietary support for sphingolipid metabolism includes adequate intake of phosphatidylcholine (found in eggs, soy lecithin, organ meats), which provides the phospholipid head-groups for sphingomyelin synthesis, and serine, the amino acid backbone for the de novo ceramide synthesis pathway. These are supporting measures, not substitutes for topical repletion.

Interactions

rs2967677 marks the CERS4/NFILZ locus as a systemic immune regulation locus — the GWAS meta-analysis explicitly highlighted this category of hits. Other autoimmune-inflammation SNPs affecting IgE signalling, Th2 cytokine pathways (IL-4/IL-13 axis), and skin barrier genes (FLG loss-of-function variants) are the most biologically relevant interaction partners. The atopic triad — atopic dermatitis, allergic rhinitis, and asthma — shares substantial genetic architecture, and rs2967677 likely contributes to the broader atopic diathesis rather than solely skin manifestation.